145 related articles for article (PubMed ID: 33466212)
1. Model establishment of prognostic-related immune genes in laryngeal squamous cell carcinoma.
Sun M; Chen S; Fu M
Medicine (Baltimore); 2021 Jan; 100(2):e24263. PubMed ID: 33466212
[TBL] [Abstract][Full Text] [Related]
2. Six Glycolysis-Related Genes as Prognostic Risk Markers Can Predict the Prognosis of Patients with Head and Neck Squamous Cell Carcinoma.
Chen L; He X; Yi S; Liu G; Liu Y; Ling Y
Biomed Res Int; 2021; 2021():8824195. PubMed ID: 33628816
[TBL] [Abstract][Full Text] [Related]
3. An immune-related lncRNA pairs signature to identify the prognosis and predict the immune landscape of laryngeal squamous cell carcinoma.
Qian L; Ni T; Fei B; Sun H; Ni H
BMC Cancer; 2022 May; 22(1):545. PubMed ID: 35568824
[TBL] [Abstract][Full Text] [Related]
4. A model of seven immune checkpoint-related genes predicting overall survival for head and neck squamous cell carcinoma.
Song D; Tian J; Han X; Li X
Eur Arch Otorhinolaryngol; 2021 Sep; 278(9):3467-3477. PubMed ID: 33449165
[TBL] [Abstract][Full Text] [Related]
5. [Establishment and validation of prognostic risk score model for esophageal squamous cell carcinoma based on immune related genes].
Liu HR; Jiang GZ; Xin D; Yang YL; Fan QX; Meng XR; Li SL; Liu Y; Xia J; Wang F
Zhonghua Zhong Liu Za Zhi; 2021 Jun; 43(6):666-673. PubMed ID: 34289558
[No Abstract] [Full Text] [Related]
6. Development and Validation of Epigenetic Signature Predict Survival for Patients with Laryngeal Squamous Cell Carcinoma.
Cui J; Wang L; Zhong W; Chen Z; Chen J; Yang H; Liu G
DNA Cell Biol; 2021 Feb; 40(2):247-264. PubMed ID: 33481663
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological value of hematopoietic cell kinase overexpression in laryngeal squamous cell carcinoma tissues.
Xia S; Li JD; Yan SB; Huang ZG; Liu ZS; Jing SW; Li DZ; Song C; Chen Y; Wang LT; Zhou YH; Huang R; Shi N; Lan SY; Chen G; Fan XH
Pathol Res Pract; 2023 Jul; 247():154534. PubMed ID: 37201466
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic and Prognostic Value of Fibrinogen, Fibrinogen Degradation Products, and Lymphocyte/Monocyte Ratio in Patients With Laryngeal Squamous Cell Carcinoma.
Han Y; Ren Z; Liu Y; Liu Y
Ear Nose Throat J; 2024 May; 103(5):NP278-NP288. PubMed ID: 34672822
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of neuropilin-2 expression in laryngeal squamous cell carcinoma.
Yin D; Guo L; Li S; Tuerdi A; Yang X; Tang Q; Wang S; Liu J; Huang P; Li M
Am J Otolaryngol; 2020; 41(4):102540. PubMed ID: 32480134
[TBL] [Abstract][Full Text] [Related]
10. Aberrant expressed long non-coding RNAs in laryngeal squamous-cell carcinoma.
Li H; Wang FL; Li W; Fei YH; Wang YT; Zhang JE; Bi HY; Zhang M
Am J Otolaryngol; 2019; 40(5):615-625. PubMed ID: 31128861
[TBL] [Abstract][Full Text] [Related]
11. The analysis of tumor-infiltrating immune cell and ceRNA networks in laryngeal squamous cell carcinoma.
Li D; Dong K; Su J; Xue H; Tian J; Wu Y; Wang J
Medicine (Baltimore); 2022 Aug; 101(31):e29555. PubMed ID: 35945754
[TBL] [Abstract][Full Text] [Related]
12. Tumor Mutation Burden, Immune Cell Infiltration, and Construction of Immune-Related Genes Prognostic Model in Head and Neck Cancer.
Jiang AM; Ren MD; Liu N; Gao H; Wang JJ; Zheng XQ; Fu X; Liang X; Ruan ZP; Tian T; Yao Y
Int J Med Sci; 2021; 18(1):226-238. PubMed ID: 33390791
[No Abstract] [Full Text] [Related]
13. Prognostic value of novel immune-related genomic biomarkers identified in head and neck squamous cell carcinoma.
Yao Y; Yan Z; Lian S; Wei L; Zhou C; Feng D; Zhang Y; Yang J; Li M; Chen Y
J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32719094
[TBL] [Abstract][Full Text] [Related]
14. A Five-mRNA Expression Signature to Predict Survival in Oral Squamous Cell Carcinoma by Integrated Bioinformatic Analyses.
Guo H; Li C; Su X; Huang X
Genet Test Mol Biomarkers; 2021 Aug; 25(8):517-527. PubMed ID: 34406843
[No Abstract] [Full Text] [Related]
15. Identification and potential mechanisms of a 4-lncRNA signature that predicts prognosis in patients with laryngeal cancer.
Zhang G; Fan E; Zhong Q; Feng G; Shuai Y; Wu M; Chen Q; Gou X
Hum Genomics; 2019 Aug; 13(1):36. PubMed ID: 31416476
[TBL] [Abstract][Full Text] [Related]
16. Construction and validation of immune-related LncRNAs classifier to predict prognosis and immunotherapy response in laryngeal squamous cell carcinoma.
Wang X; Pan Y; Ou Y; Duan T; Zou Y; Zhou X
World J Surg Oncol; 2022 May; 20(1):164. PubMed ID: 35606755
[TBL] [Abstract][Full Text] [Related]
17. The matrix metalloproteinase gene family: a significant prognostic gene lineage correlated with immune infiltrates in laryngeal squamous cell carcinoma.
Yang C; Cao H; Yang JW; Liu T; Wang JT; Wang BS
Neoplasma; 2021 Nov; 68(6):1212-1224. PubMed ID: 34585589
[TBL] [Abstract][Full Text] [Related]
18. LMX1B mRNA expression and its gene body CpG methylation are valuable prognostic biomarkers for laryngeal squamous cell carcinoma.
Fan L; Zhang A; Deng P
Biomed Pharmacother; 2019 Sep; 117():109174. PubMed ID: 31387183
[TBL] [Abstract][Full Text] [Related]
19. Glycolysis related gene expression signature in predicting prognosis of laryngeal squamous cell carcinoma.
Lau HC; Shen Y; Huang Q; Huang HY; Zhou L
Bioengineered; 2021 Dec; 12(1):8738-8752. PubMed ID: 34565301
[TBL] [Abstract][Full Text] [Related]
20. Development and validation of a novel ferroptosis-related gene signature for predicting prognosis and immune microenvironment in head and neck squamous cell carcinoma.
He F; Chen Z; Deng W; Zhan T; Huang X; Zheng Y; Yang H
Int Immunopharmacol; 2021 Sep; 98():107789. PubMed ID: 34130150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]